New Frontiers in Structure-Based Drug Discovery was a complete success!
On September 23 - 25, the international conference New Frontiers in Structure-Based Drug Discovery was held at Convitto della Calza in Florence https://www.nfsdd.eu/. 140 participants, that include 10 internationally renowned invited speakers and 80 poster presenters discussed current trends in fragment-based drug discovery. The presentations covered topics ranging from structure-beased and computational drug discovery, chemical biology, biophysical methods, intrinsically disordered proteins to peptides and natural products in drug development.
"With this international conference, concluding the two MSC Innnovative Training programs AEGIS and TASPPI lays the foundation for a sustainable exchange of ideas and cross-border discussions by a new generation of scientists", explains co-organizer Prof Michael Sattler, Director of the Institute of Structural Biology at Helmholtz Zentrum München.
"The New Frontiers in Structure-Based Drug Discovery highlights once more the need to develop new ideas in early stage drug discovery at the interface of life sciences and chemistry. For this, joint efforts of academic and industry-driven research are needed and young scientists educated in interdisciplinary and intersectoral environments to help to solve hard-to-crack biomedical problems " said co-organizer Prof. Christian Ottmann, Professor for Molecular Cell and Structural Biology at Eindhoven University of Technology .
The conference was accompanied by a satellite workshop of the company BioSolveIT on "Modeling for anyone".